Trials / Completed
CompletedNCT03597256
Restylane Defyne for Correction of Chin Retrusion
A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Effectiveness and Safety of Restylane Defyne for Correction of Chin Retrusion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 148 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, evaluator-blinded, no-treatment controlled study in subjects with Chin Retrusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane Defyne | Intradermal injection |
Timeline
- Start date
- 2018-10-08
- Primary completion
- 2019-09-24
- Completion
- 2020-09-09
- First posted
- 2018-07-24
- Last updated
- 2024-06-12
- Results posted
- 2024-06-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03597256. Inclusion in this directory is not an endorsement.